President Donald Trump disclosed Thursday that he recently held a meeting with Vas Narasimhan, the top executive of Swiss pharmaceutical giant Novartis, at the White House on Wednesday.
Speaking to employees at a steel manufacturing facility in Rome, Georgia, Trump revealed that Narasimhan informed him the company is constructing 11 manufacturing facilities across the United States, crediting the president’s tariff strategies for spurring this investment.
In response to inquiries, a Novartis representative provided a statement to Reuters saying, “We appreciate the opportunity to update the U.S. government on our progress, including recent groundbreakings for manufacturing and research facilities in North Carolina and California and plans to expand our radioligand therapy manufacturing network with a new site in Florida.”
However, the company’s official response did not confirm specific numbers regarding how many facilities are planned for construction on American soil.
Previously, the Swiss pharmaceutical company announced intentions to invest $23 billion in constructing and expanding 10 facilities throughout the United States following the Trump administration’s warnings about potential import tariffs on pharmaceutical products.
